On Thursday, December 31, 2020, China approved its first COVID-19 vaccine developed by a Chinese state-backed pharmaceutical company, Sinopharm, founded by China National Pharmaceutical Group (CNPG).
As per the claim of the vaccine producer, Beijing Biological Products Institute, a subsidiary of CNPG, the vaccine was found 79.34% effective against the COVID-19 based on the interim analysis.
However, the clinical result of the vaccine efficacy rate is comparatively lower as compared to other peer competitors including vaccine candidates from AstraZeneca and Pfizer.
Read more on toopanda.com